Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness

British Journal of Cancer

Volumn 74, Issue 11, 1996, Pages 1693-1698

  Aryee, D N T ^a   Simonitsch, I ^b   Mosberger, I ^b   Kos, K ^a   Mann, G ^a   Schlogl E ^c   Potschger U ^a   Gadner, H ^a   Radaszkiewicz, T ^b   Kovar, H ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c HANUSCH HOSPITAL   (Austria)

Author keywords

Hodgkin's disease; Immunohistochemistry; nm23 H1; Non Hodgkin's lymphoma

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE MUTATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; NONHODGKIN LYMPHOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 10544221233     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.616     Document Type: Article

References (32)

1. ARYEE DNT, STRÖBEL T, KOS K, SALZER-KUNTSCHIK M, ZOUBEK A, VERON M, AMBROS IM, TRAINCART F, GADNER H AND KOVAR H. (1995). High nm23-H1/NDPK-A expression tumours: paradoxical immunohistochemical reactivity and lack of prognostic significance. Int. J. Cancer, 64, 104-111.
2. BACKER JM, MENDOLA CE, KOVESDI I, FAIRHURST JL, O'HARA B, EDDY JR RL, SHOWS TB, MATHEW S, MURTY VVVS AND CHAGANTI RSK. (1993). Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis suppressor genes NM23-H1 and NM23-H2. Oncogene, 8, 497-502.
3. BARNES R, MASOOD S, BARKER E, ROSENGARD AM, COGGIN DL, CROWELL T, KING CR, PORTER-JORDAN K, WARGOTZ ES, LIOTTA LA AND STEEG PS. (1991). Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patients survival. Am. J. Pathol., 139, 245-250.
4. BEVILACQUA G, SOEBEL ME, LIOTTA L AND STEEG PS. (1989). Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinoma indicators of high tumour metastatic potential. Cancer Res., 49, 5185-5190.
5. BIGGS J, HERPERGER E, STEEG PS, LIOTTA L AND SHEARN A. (1990). A drosophila gene that is homologous to a mammalian gene associated with tumour metatasis codes for a nucleoside diphosphate kinase. Cell, 63, 933-940.
6. CHANG CL, XIAO-XIAN Z, THORAVAL DH, UNGAR D, RAWWAS J, HORA N, STRAHLER JR, HANASH SM AND RADANY E. (1994). Nm23-H1 mutation in neuroblastoma. Nature, 370, 335-336.
7. CHOMCZYNSKI P AND SACCHI N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal. Biochem., 162, 156-159.
8. COHN KH, WANG F, DESOTO-LAPAIX F, SOLOMON WB, PATTERSON LG, ARNOLD MR, WEIMER J, FELDMAN JG, LEVY AT, LEONE A AND STEEG PS. (1991). Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet. 338, 722-724.
9. DAWKINS HJS, GOODALL RJ, HÄHNEL E, SARNA M, ROBBINS PD, DEKLERK N, HÄHNEL R, PAPADIMITRIOU JM, HARVEY JM AND STERRETT GF. (1993). Nm23-H1 metastasis suppressor gene expression in primary breast cancer. Associations with lymph node status, tumour size, type and grade. Breast, 2, 239-245.
10. ENGEL M, THEISINGER B, SEIB T, SEITZ G, HUWER H, ZANG KD, WELTER C AND DOOLEY S. (1993). High levels of nm23-H1 and nm23-H2 mRNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumour stages. Int. J. Cancer, 55, 375-378.
11. FLORENES VA, AAMDAL S, MYKLEBOST O, MAELANDSMO M, BRULAND OS AND FOTSTAD O. (1992). Levels of nm23 RNA in metastatic malignant melanomas. Inverse correlation to disease progression. Cancer Res., 52, 6088-6091.
12. GAYNOR ER AND ULTMANN JE. (1984). Non-Hodgkin's lymphoma: management strategies. N. Engl. J. Med., 311, 1506-1508.
13. GILLES AM, PRESECAN E, VONICA A AND LASCU I. (1991). Nucleoside diphosphate kinase from human erythrocytes. J. Biol. Chem., 266, 8784-8789.
14. HAILAT N, KEIM DR, MELHEM RF, ZHU XX, ECKERSKORN C, BRODEUR GM, REYNOLDS CP, SEEGER RC, LOTTSPEICH F, STRAHLER JR AND HANASH SM. (1991). High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with n-myc gene amplification. J. Clin. Invest., 88, 341-345.
15. HARRIS NL, JAFFE ES, STEIN H, BANKS PM, CHAN JKC, CLEARY ML, DELSOL G, WOLF-PEETERS CD, FALINI B, GATTER KC, GROGAN TM, ISAACSON PG, KNOWLES DM, MASON DY, MULLER-HERMELINK H-K, PILERI SA, PIRIS MA, RALFKIAER E AND WARNKE RA. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392.
16. HENNESSY C, HENRY JA, MAY FEB, WESTLEY BR, ANGUS B AND LENNARD TWJ. (1991). Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl Cancer Inst., 83, 281-285.
17. HIRAYAMA R, SAWAI S, TAGAKI Y, MISHIMA Y, KIMURA N, SHIMADA N, ESAKI Y, KURASHIMA C, UTSUYAMA M AND HIROKAWA K. (1991). Positive relationship between expression of anti-metastatic factor (nm23 gene product of nucleoside diphosphate kinase) and good prognosis in human breast cancer. J. Natl Cancer Inst., 83, 1249-1250.
18. HORNING SJ AND ROSENBERG SA. (1984). The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med., 98, 1471-1475.
19. IGAWA M, RUKSTALIS DB, TANABE T AND CHODAK GW. (1994). High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res., 54, 1313-1318.
20. KATH R, DONHUIJSEN K, HAYUNGS J, ALBRECHT K, SEEBER S AND HÖFFKEN K. (1995). Primary gastric non-Hodgkin's lymphoma: a clinicopathological study of 41 patients. J. Cancer Res. Clin. Oncol., 121, 51-56.
21. KEIM D, HAILAT N, MELHEM R, ZHU XX, LASCU I, VERON M AND STRAHLER JJ. (1992). Proliferation-related expression of p19/ nm23 nucleoside diphosphate kinase. J. Clin. Invest., 89, 919-924.
22. LACOMBE ML, WALLET V, TROLL H AND VERON M. (1990). Functional cloning of a nucleoside diphosphate kinase from Dictyostelium discoideum. J. Biol. Chem., 265, 10012-10018.
23. LEONE A, FLATOW U, RICHTER-KING C, SANDEEN MA, MARGULIES IMK, LIOTTA L AND STEEG PS. (1991). Reduced tumour incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65, 25-35.
24. LEONE A, FLATOW U, VANHOUTTE K AND STEEG PS. (1993a). Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumour metastatic potential, colonization and enzymatic activity. Oncogene, 8, 2325-2333.
25. LEONE A, SEEGER RC, HONG CM, HU YY, ARBOLEDA MJ, BRODEUR GM, STRAM D, SLAMON DJ AND STEEG PS. (1993b). Evidence for nm23 RNA overexpression. DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 8, 855-865.
26. NAKAYAMA T, OHTSURU A, NAKAO K, SHIMA M, NAKATA K, WATANABE K, ISHII N, KIMURA N AND NAGATAKI S. (1992). Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J. Natl Cancer Inst., 84, 1349-1354.
27. POSTEL EH, BERBERICH SJ, FLINT SJ AND FERRONE CA. (1993). Human c-myc transcription factor Puf identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumour metastasis. Science, 261, 478-480.
28. ROSENGARD AM, KRUTZSCH HC, SHEARN A, BIGGS JR, BARKER E, MARGULIES IMK, KING CR, LIOTTA LA AND STEEG PS. (1989). Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature, 342, 177-180.
29. SASTRE-GARAU X, LACOMBE ML, JOUVE M, VERON M AND MAGDELENAT H. (1992). Nucleoside diphosphate kinase, NM23 expression in breast cancer: lack of correlation with lymph-node metastasis. Int. J. Cancer. 50, 533-538.
30. STAHL JA, LEONE A, ROSENGARD AM, PORTER L, KING CR AND STEEG PS. (1991). Identification of a second human nm23 gene. nm23-H2. Cancer Res., 51, 445-449.
31. STEEG PS, BEVILACQUA G, KOPPER L, THORGEIRSSON UP, TALMADGE JE, LIOTTA LA AND SOEBEL ME. (1988). Evidence for a novel gene associated with low tumour metastatic potential. J. Natl Cancer Inst., 80, 200-204.
32. ZENG ZS, HSU S, ZHANG ZF, COHEN AM, ENKER WE, TURNBULI, AA AND GUILLEM JG. (1994). High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases. Br. J. Cancer, 70, 1025-1030.